Cargando…
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Breast cancer is the most common cancer and the deadliest among women worldwide. Estrogen signaling is closely associated with hormone-dependent breast cancer (estrogen and progesterone receptor positive), which accounts for two-thirds of tumors. Hormone therapy using antiestrogens is the gold stand...
Autores principales: | Clusan, Léa, Ferrière, François, Flouriot, Gilles, Pakdel, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095386/ https://www.ncbi.nlm.nih.gov/pubmed/37047814 http://dx.doi.org/10.3390/ijms24076834 |
Ejemplares similares
-
A Closer Look at Estrogen Receptor Mutations in Breast Cancer and Their Implications for Estrogen and Antiestrogen Responses
por: Clusan, Léa, et al.
Publicado: (2021) -
Unliganded Estrogen Receptor Alpha Promotes PC12 Survival during Serum Starvation
por: Ferriere, François, et al.
Publicado: (2013) -
Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
por: Pham, Thu Ha, et al.
Publicado: (2021) -
Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor‐alpha protein in breast cancer cells
por: Clusan, Léa, et al.
Publicado: (2023) -
Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
por: Lecomte, Sylvain, et al.
Publicado: (2017)